Lentiviral vectors for cancer immunotherapy transforming infectious particles into therapeutics

Target ArticleEdit

Lentiviral vectors for cancer immunotherapy transforming infectious particles into therapeutics; K Breckpot, JL Aerts, K Thielemans; 2007; doi_citing_unknown

RetractionEdit

RETRACTED ARTICLE: How can SLCA influence change to a product’s life cycle and who listens to the impacts of an SLCA?; Choi, Hee Sun; ; 2016-4-01

https://doi.org/10.1007/s10668-015-9662-x

Citation pieceEdit

Note: Open to append information.